Healthcare
Novo Seeds, the early stage investment arm of Novo Holdings, wholly owned by the Novo Nordisk Foundation, announced that its advisory unit, BiOrigin, has appointed several seasoned entrepreneurs to its team.
Kura Oncology, Inc. announced that Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to participate in a fireside chat at the 31st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 12:00 p.m. ET / 9:00 a.m. PT.
Safety and efficacy evaluation will be performed on 36 patients from 3 hospitals located in US and Australia
New Facility for Maravai’s TriLink BioTechnologies Set to Supercharge messengerRNA Therapeutics Development
Philadelphia, PA – Oncoceutics, Inc. announced that new data will be presented on the efficacy and mechanism of action of imipridones ONC201 and ONC206 at the 24th Annual Scientific Meeting of the Society of Neuro-Oncology, to be held November 20th-24th in Phoenix, Arizona.
Series A round lead investors NordicNinja and Industrifonden to support Combinostics as they scale to US and Asia
Oncoceutics, Inc. announced a publication in the journal Nature Communications demonstrating selective antagonism of the G-protein coupled receptor dopamine receptor D2 by Oncoceutics’ lead candidate imipridone, ONC201.
KidneyX seeks breakthrough solutions to transform kidney care
Hertfordshire Local Enterprise Partnership is to invest £1.2m into Stevenage Bioscience Catalyst (SBC) to help grow a world-class cell and gene therapy cluster.
Global BioLife Inc, the U.S. subsidiary of Singapore eDevelopment Ltd, will present its 3F Antimicrobial Fragrance as a new method to prevent and treat Tuberculosis at the ASM Biothreats Conference, 28 to 30 January, 2020 in Arlington, Virginia.
PRESS RELEASES